How do doctors choose between chromosome tests protein tests and DNA tests for genetic disease?

Doctors select between chromosome, protein, and DNA tests based on the nature of the suspected genetic abnormality, the accessibility of the gene product, cost-effectiveness, and the clinical context of the patient.12

Choosing the Appropriate Test

• Chromosome Tests (Karyotyping/FISH): These are chosen when the suspected defect involves large-scale chromosomal aberrations, such as aneuploidy (e.g., Down syndrome) or large structural rearrangements involving hundreds or thousands of genes.31
• Protein (Biochemical) Tests: These are often preferred when the gene product (such as blood or enzymes) is readily accessible and the test is more cost-effective than DNA analysis. For example, screening for sickle cell anemia may initially involve testing hemoglobin proteins. Biochemical assays are also used to detect metabolic defects like phenylketonuria.14
• DNA Tests: These are highly powerful and versatile, capable of detecting specific mutations down to a single base pair. They are chosen when high sensitivity is required or when no cheap, accurate protein-based alternative exists, such as in cystic fibrosis screening. DNA tests are advantageous because they can be performed on tiny samples from almost any tissue type, regardless of whether the gene is expressed in that tissue.51

The choice also depends on whether the goal is population-wide newborn screening, carrier testing, or diagnostic testing for individuals at high risk due to family history.1